ADVANCES IN TREATMENT OF METASTATIC BREAST CANCER
Mohammad Sabry El Kady;
Abstract
The work is a comparative, randomized study to assess the effect of chemotherapy (paclitaxel) as a single agent or combined with trastuzumab (HER2 monoclonal antibodies against HER2 receptors in palliative treatment of metastatic breast cancer patients wh
Other data
| Title | ADVANCES IN TREATMENT OF METASTATIC BREAST CANCER | Authors | Mohammad Sabry El Kady | Keywords | ADVANCES IN TREATMENT OF METASTATIC BREAST CANCER | Issue Date | 2003 | Description | The work is a comparative, randomized study to assess the effect of chemotherapy (paclitaxel) as a single agent or combined with trastuzumab (HER2 monoclonal antibodies against HER2 receptors in palliative treatment of metastatic breast cancer patients wh |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.